X‐linked creatine transporter deficiency: clinical aspects and pathophysiology
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Creatine transporter deficiency was discovered in 2001 as an X‐linked cause of intellectual disability characterized by cerebral creatine deficiency. This review describes the current knowledge regarding creatine metabolism, the creatine transporter and the clinical aspects of creatine transporter deficiency. The condition mainly affects the brain while other creatine requiring organs, such as the muscles, are relatively spared. Recent studies have provided strong evidence that creatine synthesis also occurs in the brain, leading to the intriguing question of why cerebral creatine is deficient in creatine transporter deficiency. The possible mechanisms explaining the cerebral creatine deficiency are discussed. The creatine transporter knockout mouse provides a good model to study the disease. Over the past years several treatment options have been explored but no treatment has been proven effective. Understanding the pathogenesis of creatine transporter deficiency is of paramount importance in the development of an effective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 20×
“AGAT and GAMT expression and creatine synthesis has also been detected in the Müller cells of the retina (Nakashima et al 2005).”
InfluentialElevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168 · cited 1×
“…in healthy humans led to a maximal 5-15% increase of total creatine levels in the brain (Dechent et al 1999) and a mean increase of 20 % to maximal 140–160 mmol/ kg dry muscle in skeletal muscle with the largest increases in subjects with a low initial total creatine content (Harris et al 1992).”
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417 · cited 17×
“GAMT-deficiency (GAMT-D) was first described in 1994 (Stockler et al 1994), followed by the discovery of both CRTR-D and AGAT deficiency (AGATD) in 2001 (Salomons et al 2001; Cecil et al 2001; Item et al 2001).”
InfluentialCreatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
Is it time to reevaluate methyl balance in humans?
Stead, L. M., Brosnan, J. T., Brosnan, M. E., Vance, D. E., & Jacobs, R. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.1.5 · Cited by 278 · cited 1×
“A typical Western diet supplies about one-half of the daily creatine need (Brosnan and Brosnan 2007; Brosnan et al 2011; Stead et al 2006).”
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
Dechent, P., Pouwels, P. J. W., Wilken, B., Hanefeld, F., & Frahm, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r698 · Cited by 221
Creatine deficiency syndromes and the importance of creatine synthesis in the brain
Braissant, O., Henry, H., Béard, E., & Uldry, J. (2011) · Amino Acids · doi:10.1007/s00726-011-0852-z · Cited by 145
Stimulatory effect of insulin on creatine accumulation in human skeletal muscle
Steenge, G. R., Lambourne, J., Casey, A., Macdonald, I. A., & Greenhaff, P. L. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.6.e974 · Cited by 125 · cited 1×
“…concentrations), and insulin-like growth factor I increase creatine uptake (Wyss and Kaddurah-Daouk 2000; Snow and Murphy 2001; Odoom et al 1996; Steenge et al 1998), probably mainly indirectly by stimulating Na+/K+-ATPase and therefore increasing the sodium gradient across the cell membrane…”
Ipsiroglu, O. S., Stromberger, C., Ilas, J., Höger, H., Mühl, A., & Stöckler-Ipsiroglu, S. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01268-1 · Cited by 122
Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112 · cited 8×
“In creatine synthesis defects, supplementation with creatine is able to restore cerebral creatine, confirming that creatine crosses the BBB.”
InfluentialGuanidinoacetate methyltransferase deficiency: New clinical features
Ganesan, V., Johnson, A., Connelly, A., Eckhardt, S., & Surtees, R. A. H. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00083-0 · Cited by 108
The regulation of total creatine content in a myoblast cell line
Odoom, J., Kemp, G., & Radda, G. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00225844 · Cited by 101 · cited 2×
“…supraphysiological concentrations), and insulin-like growth factor I increase creatine uptake (Wyss and Kaddurah-Daouk 2000; Snow and Murphy 2001; Odoom et al 1996; Steenge et al 1998), probably mainly indirectly by stimulating Na+/K+-ATPase and therefore increasing the sodium gradient across…”
Battini, R., Alessandrì, M. G., Leuzzi, V., Moro, F., Tosetti, M., Bianchi, M. C., & Cioni, G. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.043 · Cited by 101 · cited 2×
“In AGAT-D (Edvardson et al 2010; Nouioua et al 2013; Verma 2010; Ndika et al 2012; Bianchi et al 2007; Battini et al 2006; Item et al 2001) and GAMT-D (Mercimek-Mahmutoglu et al 2006; Stockler-Ipsiroglu et al) creatine supplementation (in combination with L-ornithine and arginine restriction in…”
Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency
Kurosawa, Y., DeGrauw, T. J., Lindquist, D. M., Blanco, V. M., Pyne-Geithman, G. J., Daikoku, T., Chambers, J. B., Benoit, S. C., & Clark, J. F. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59373 · Cited by 98
Dissociation of AGAT, GAMT and SLC6A8 in CNS: Relevance to creatine deficiency syndromes
Braissant, O., Béard, E., Torrent, C., & Henry, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.022 · Cited by 94 · cited 3×
“AGAT and GAMT expression in brain has been extensively confirmed in rat (Braissant et al 2001; Braissant and Henry 2008; Braissant et al 2010) and mouse (Daly and Seifter 1980; Tachikawa et al 2004; Schmidt et al 2004) but is also present in human brain (Van Pilsum et al 1972; Schmidt et al 2004;…”
Ensenauer, R., Thiel, T., Schwab, K. O., Tacke, U., Stöckler-Ipsiroglu, S., Schulze, A., Hennig, J., & Lehnert, W. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.005 · Cited by 71 · cited 3×
“However, restoration takes months and high doses of creatine are needed (Stockler et al 1996; Leuzzi et al 2000; Schulze et al 2003; Ensenauer et al 2004; Verbruggen et al 2007a; Edvardson et al 2010; Verma 2010; Kan et al 2007) consistent with a limited permeability of the BBB for creatine.”
Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect
van de Kamp, J. M., Pouwels, P. J. W., Aarsen, F. K., ten Hoopen, L. W., Knol, D. L., de Klerk, J. B., de Coo, I. F., Huijmans, J. G. M., Jakobs, C., van der Knaap, M. S., et al. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9345-1 · Cited by 59
Self-citationNdika, J. D. T., Johnston, K., Barkovich, J. A., Wirt, M. D., O'Neill, P., Betsalel, O. T., Jakobs, C., & Salomons, G. S. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.01.017 · Cited by 40
Self-citationTrotier-Faurion, A., Dézard, S., Taran, F., Valayannopoulos, V., de Lonlay, P., & Mabondzo, A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400545n · Cited by 36 · cited 1×
“Unfortunately, the creatine esters are subject to rapid degradation to creatinine (Lunardi et al 2006; Adriano et al 2011; Trotier-Faurion et al 2013) and no effect of treatment with creatine-ethyl-ester was found in CRTR-D patients (Fons et al 2010).”
Genotype–phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1
van de Kamp, J. M., Errami, A., Howidi, M., Anselm, I., Winter, S., Phalin‐Roque, J., Osaka, H., van Dooren, S. J. M., Mancini, G. M., Steinberg, S. J., et al. (2015) · Clinical Genetics · doi:10.1111/cge.12355 · Cited by 33
Self-citationVerbruggen, K. T., Knijff, W. A., Soorani-Lunsing, R. J., Sijens, P. E., Verhoeven, N. M., Salomons, G. S., Goorhuis-Brouwer, S. M., & van Spronsen, F. J. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-006-0340-8 · Cited by 17
Self-citationClinical Applications of Creatine Supplementation on Paediatrics
Evangeliou, A., Vasilaki, K., Karagianni, P., & Nikolaidis, N. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109789542075 · Cited by 16
Cited by
Creatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Balestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes
Clark, J. F., & Cecil, K. M. (2015) · Pediatric Research · doi:10.1038/pr.2014.203 · Cited by 61
SLC6 Transporter Folding Diseases and Pharmacochaperoning
Freissmuth, M., Stockner, T., & Sucic, S. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_71 · Cited by 42
Metadata
- Authors
- van de Kamp, J. M., Mancini, G. M., & Salomons, G. S.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2014-05
- Volume
- 37
- Issue
- 5
- Pages
- 715-733
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2045347081
- Cited by
- 118
- References
- 24
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.